Multiple Scenarios, Going Forward

The ability to see multiple scenarios is like a Rorschach Test.

With each additional tick on the chart, it takes on a different character.

So, let’s look at what’s most likely, based on where we are now with one of, if not the weakest sectors; biotech SPBIO.

For reference, we’ll start with the big picture … the weekly chart to show the two-month long, bear flag.

Biotech SPBIO, Weekly

Next, is the daily for the past several months.

We’re at The Danger Point®; the test, where there’s not much distance between pass and fail.

Price action can (easily) go either way.

SPBIO, Daily

However, from a probability standpoint, we’ve been in a bear flag for months; the expectation is the test will pass, price action reverses and we get a downside breakout.

The hourly chart has the most likely potential outcome.

Pre-market action shows flat (as of 9:08 a.m., EST).

SPBIO, Hourly

The chart has two likely scenarios: one pass, one fail.

A less likely outcome is a straight up launch above resistance.

However, anything can happen.

Summary

With the Fed out talking hawkish again, we’ll say it again; there is no ‘pivot’.

Whether or not the press is intentionally miss-directing the narrative, in a sense, does not matter.

We’re looking at the price action.

Right now, it says, we’re at a dangerous spot and may be about to pivot (pun intended) to the downside.

Positioning

Not advice, not a recommendation.

No change since yesterday.

Short position in SPBIO via LABD; details are as follows:

LABD-22-13:

Entry @ 18.72: Stop @ TBD

Note: Positions may be increased, decreased, entered, or exited at any time.

***, Indicates change

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279